Promising treatment for cancer-related fatigue
09 Oct 2023 by Ted Escobedo 1 min read
In a new study led by Yale Cancer Center researchers at Yale School of Medicine, the team found that a metabolism-targeting drug called dichloroacetate (DCA) helped alleviate CRF in mice, without interfering with cancer treatments. The findings are a pathway for future CRF research that may someday lead to a new therapy for patients.
The results were published in American Journal of Physiology-Endocrinology and Metabolism on Oct. 2.
Know more: https://www.sciencedaily.com/releases/2023/10/2310...
- Tags:
- News